Kyntra Bio: Q3 Earnings Snapshot

Résumé détaillé
SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Kyntra Bio, Inc. (KYNB) on Monday reported third-quarter profit of $157,000. The San Francisco-based company said it had profit of 4…
SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Kyntra Bio, Inc. (KYNB) on Monday reported third-quarter profit of $157,000.
The San Francisco-based company said it had profit of 4 cents per share. Losses, adjusted for non-recurring gains, were $3.42 per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $3.66 per share.
The biotech drug developer posted revenue of $1.8 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $2 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KYNB at https://www.zacks.com/ap/KYNB
Début de l'article, extrait de Yahoo Finance. Pour lire la suite, ouvrez l'article chez le média.
MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)



